Global Adeno Associated Virus Vector Manufacturing Market Size & Outlook
Global adeno associated virus vector manufacturing market, 2018-2030 (US$M)
Related Markets
Global adeno associated virus vector manufacturing market highlights
- The global adeno associated virus vector manufacturing market generated a revenue of USD 1,020.1 million in 2024 and is expected to reach USD 2,778.5 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 18.5% by 2030.
- In terms of segment, clinical accounted for a revenue of USD 564.6 million in 2024.
- Commercial is the most lucrative scale of operations segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 1,020.1 million |
| Market revenue in 2030 | USD 2,778.5 million |
| Growth rate | 18.5% (CAGR from 2025 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Commercial |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Preclinical, Commercial |
Other key industry trends
- In terms of revenue, the North America accounted for 49.8% of the global adeno associated virus vector manufacturing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 106.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Adeno Associated Virus Vector Manufacturing Market Scope
Adeno Associated Virus Vector Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global adeno associated virus vector manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to adeno associated virus vector manufacturing market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 55.35% in 2024. Horizon Databook has segmented the Global adeno associated virus vector manufacturing market based on clinical, preclinical, commercial covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Adeno Associated Virus Vector Manufacturing Scale of Operations Outlook (Revenue, USD Million, 2018-2030)
- Clinical
- Preclinical
- Commercial
- Global Adeno Associated Virus Vector Manufacturing Application Outlook (Revenue, USD Million, 2018-2030)
- Cell Therapy
- Gene Therapy
- Vaccine
- Global Adeno Associated Virus Vector Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Hematological Diseases
- Infectious Diseases
- Genetic Disorders
- Neurological Disorders
- Ophthalmic Disorders
- Others
- Global Adeno Associated Virus Vector Manufacturing Method Outlook (Revenue, USD Million, 2018-2030)
- In Vitro
- In Vivo
Reasons to subscribe to Global adeno associated virus vector manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global adeno associated virus vector manufacturing market databook
-
Our clientele includes a mix of adeno associated virus vector manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global adeno associated virus vector manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global adeno associated virus vector manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global adeno associated virus vector manufacturing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Adeno associated virus vector manufacturing market size, 2024 (US$M)
Global adeno associated virus vector manufacturing market share, by scale of operations, 2024 & 2030 (%, US$M)
Adeno associated virus vector manufacturing market: Opportunity assessment by country
Global adeno associated virus vector manufacturing market, by region, 2024 (US$M)
| Scale of Operation... | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 202.4 | 232.4 | 273.0 | 335.2 | 382.1 | 439.3 | 508.2 | 591.0 | 690.9 | 812.1 | 960.0 | 1,141.2 | 1,364.5 | 18.2% |
| Europe | 110.6 | 126.8 | 148.8 | 182.4 | 207.6 | 238.3 | 275.2 | 319.6 | 373.1 | 437.8 | 516.7 | 613.3 | 732.1 | 18.0% |
| Asia Pacific | 64.2 | 74.3 | 88.1 | 109.5 | 126.5 | 147.9 | 174.3 | 207.1 | 248.2 | 300.0 | 365.9 | 450.5 | 560.3 | 22.0% |
| Latin America | 21.1 | 23.5 | 26.6 | 31.6 | 34.7 | 38.4 | 42.7 | 47.7 | 53.5 | 60.3 | 68.2 | 77.4 | 88.4 | 13.1% |
| MEA | 11.3 | 12.3 | 13.6 | 15.7 | 16.8 | 18.2 | 19.6 | 21.3 | 23.2 | 25.3 | 27.6 | 30.3 | 33.4 | 9.4% |
| Overall | 409.5 | 469.2 | 550.1 | 674.4 | 767.7 | 881.9 | 1,020.1 | 1,186.7 | 1,388.8 | 1,635.5 | 1,938.4 | 2,312.8 | 2,778.5 | 18.6% |
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
